Sign in

NCT07861477Completed

Murottal as Adjunctive Intervention in Pediatric

Quranic Auditory Stimulus (Surah Ar-Rahman) as Adjunctive Psychospiritual Intervention for Anxiety and Sleep Disturbances in Pediatric Blood Cancer: A Pilot Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 9 Oct 2026

Brief summary (registry, in English)

This study aims to evaluate whether listening to the recitation of Surah Ar-Rahman (Murottal) before bedtime can help improve anxiety and sleep quality in hospitalized children with blood cancer. Twenty children aged 8-12 years will be divided into two groups: one group will receive standard care plus the Murottal intervention for 7 days, while the other group will receive standard care only. Anxiety and sleep quality will be measured using validated questionnaires (SCARED and SDSC) before and after the intervention. We hope this study will provide evidence that Murottal can be a safe, non-invasive, and culturally appropriate supportive therapy for pediatric cancer patients.

Status (registry)
Completed
Study type
Interventional
Enrollment
20 (actual)
First submitted
30 Sept 2026
Start date
19 Dec 2025
Primary completion date
15 May 2026
Lead sponsor
Universitas Airlangga
NCT number
NCT07861477

What you commit to

  • Study type: Interventional
  • Participants enrolled: 20
  • From 19 Dec 2025 to the primary completion date, 15 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe neurological disorders.

Other

  • Medical instability or requirement for ICU care.
  • Undetected sensory or auditory impairments at baseline.
  • Withdrawal of consent.
  • Significant medical deterioration or complications requiring transfer to the pediatric ICU.
  • Did not complete at least 5 of 7 intervention sessions.

Who the study is looking for

  • Muslim pediatric patients aged 8-12 years.
  • Diagnosed with hematological malignancies (acute lymphoblastic leukemia, acute myeloid leukemia, or chronic myelogenous leukemia).
  • Hospitalized for chemotherapy.
  • Preserved auditory function (no hearing impairment).
  • Indonesian-literate guardians.
  • Baseline anxiety (SCARED score ≥25) or sleep disturbance (SDSC score \>39).

Age in the registry: 8 years to 12 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Dr. Soetomo Public Hospital
Coordinator of this site? Confirm its status
SurabayaIndonesiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.